logo
5 Ways To Win Over Your Manager In One-On-One Meetings

5 Ways To Win Over Your Manager In One-On-One Meetings

Forbes2 days ago

Employees who master one-on-one meetings establish better relationships with their manager.
Your one-on-one meetings with your manager aren't just routine check-ins. They're your most underutilized tool for career advancement. Yet nearly half of employees rate their one-on-ones as 'suboptimal,' according to research conducted by Steven Rogelberg, Chancellor's Professor at the University of North Carolina at Charlotte. Meanwhile, employees who master these conversations build stronger relationships, gain invaluable mentorship and position themselves for promotion.
The stakes couldn't be higher. In today's workplace, where 77% of employees are either not engaged or actively disengaged, according to Gallup's State of the Global Workplace report, your ability to connect with your manager sets you apart from the crowd. Here's how to transform your one-on-one meetings from mundane status updates into impactful relationship-building and career advancement opportunities.
Too many employees walk into one-on-ones unprepared, waiting for their manager to lead the conversation and set the priorities. This passive approach wastes precious face time and signals that you're not proactive about your career development.
Effective one-on-one meetings belong to the employee, not the manager. You should be talking 50% to 90% of the time.
When you drive the conversation, you demonstrate initiative, strategic thinking, and leadership potential—all qualities managers notice and remember during promotion discussions.
Instead of waiting for your manager to ask about your projects, start with: 'I've identified three opportunities to streamline our workflow that could save the team 5 hours weekly. Can we discuss how to pilot these ideas?'
Most one-on-ones devolve into glorified status updates where employees report on completed tasks, and managers assign new ones. This approach misses the real opportunity to discuss your professional development and future trajectory.
Research conducted by Workplace Intelligence on behalf of Amazon reveals that 74% of millennial and Gen Z employees are likely to quit if they don't see career mobility opportunities. Use your one-on-ones to position yourself as someone invested in long-term growth.
Managers want to retain and develop high-performing employees. When you consistently discuss development, you demonstrate ambition and provide your manager with reasons to invest in your future.
Many employees use one-on-ones as a means to complain, bringing problems to their manager without any resolution. While it's essential to surface challenges, this approach positions you as someone who creates work for your manager rather than someone who makes their job easier.
Transform yourself from someone who brings problems to someone who brings solutions. This shift will fundamentally change how your manager perceives your value.
Managers get evaluated on their team's performance. When you consistently present solutions alongside challenges, you become an asset that makes their job easier, not harder.
'I've noticed our client response time has increased by 20%. I've researched three approaches other teams use: automated ticketing, dedicated response shifts and AI-powered triage. I think the automated system could work best for us because [reasons]. What's your take on piloting this next quarter?'
Many professionals assume that no news is good news, waiting for annual performance reviews to understand how they're really performing. This passive approach to feedback leaves you flying blind for months and missing crucial opportunities for course correction and improvement.
Microsoft research shows that employees who receive clear guidance from managers are 2.5 times more likely to maintain productivity while achieving work-life balance. Don't wait for feedback—actively seek it.
Managers appreciate employees who are coachable and committed to improvement. When you ask for feedback and act on it, you prove you're worth the investment of their time and guidance.
Many professional relationships remain surface-level, focused solely on deliverables and deadlines without any personal connection. This dynamic limits trust, reduces psychological safety and makes it harder for your manager to advocate for you when opportunities arise.
Research shows that employees become significantly more engaged when they feel their organization cares about their overall well-being. Your manager is a person first and a professional second—building that human connection transforms working relationships.
Strong relationships create psychological safety, trust and mutual investment. When your manager sees you as a whole person, they're more likely to advocate for your promotion and provide honest career guidance. When you consistently show up as someone worth investing in, you make it easy for your manager to become a powerful champion.
Organizations that invest in regular one-on-one meetings see measurable results: higher employee engagement, better talent retention and stronger team performance. But the individual benefits are even more compelling. Employees who excel in these meetings consistently report feeling more supported, clearer about their career trajectory and more confident in their professional relationships. Your one-on-one meeting is your opportunity to shape how your manager perceives your potential, your commitment and your future at the company. When you approach these conversations strategically, you're not just managing up—you're actively shaping your career path.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Joshua Jackson in custody battle with his ex-wife over daughter's schooling
Joshua Jackson in custody battle with his ex-wife over daughter's schooling

News24

time43 minutes ago

  • News24

Joshua Jackson in custody battle with his ex-wife over daughter's schooling

The ink has barely dried on Joshua Jackson and Jodie Turner-Smith's divorce papers, and already the exes are locked in a bitter legal dispute over their shared parenting arrangement. The Doctor Odyssey star has filed an emergency custody review, claiming his ex-wife enrolled their five-year-old daughter, Juno, in a new school without his consent. In the documents, obtained by People magazine, Joshua (46) alleges that Jodie (38) believes, 'it's no big deal to force Juno to start over with a new school'. He also complains that the new school is 45 minutes away from his home, making regular drop-offs and pick-ups nearly impossible for him. However, Joshua's concern goes beyond the school change itself. 'Jodie is attempting to create a scenario where Juno travels with her rather than attending a traditional school,' he claims. The Dawson's Creek star wants the court to order that their daughter remains in her current school in Calabasas, in Los Angeles, for the upcoming academic year. He also wants it stipulated that both parents must agree before any future school changes can be made. View this post on Instagram A post shared by THE AGENCY: CENTRAL INTELLIGENCE (@theagency_sho) Joshua and Jodie met at a 2018 party hosted by R&B singer Usher. They married in secret a year later before welcoming Juno in April 2020. In October 2023, the British model and actress filed for divorce on the grounds of 'irreconcilable differences'. Joshua recently told USA Today that he believes Jodie is attempting to change their daughter's schooling so there is more flexibility for Juno to accompany her when she needs to travel for work. READ MORE| 'I don't think of it as a failure' – Jodie Turner-Smith on divorcing Joshua Jackson He says he thinks maintaining educational stability is important for their daughter's well-being during her formative years – something he didn't experience as a child actor. 'I started acting at a young age. I have spent a lot of time with on-set or on-location tutors,' he said. 'Even in the best case, it cannot begin to provide a child with the same nurturing and enrichment, peer relationships and social skills that a classroom and school community environment provides.' He added that Juno has already endured a lot of changes, from their divorce to her home burning down during the LA wildfires in January, so she doesn't need any more turmoil. 'Unnecessary school change cannot be in her interests.' Jodie is yet to speak publicly on the matter. Despite their legal woes, it seems they're both moving on with their lives. View this post on Instagram A post shared by Joshua Jackson (@vancityjax) Jodie currently stars in The Agency as Dr Sami Zahir, an academic who becomes romantically involved with an undercover CIA agent. Describing her role she says, 'I love playing a dark-skinned Sudanese woman speaking Arabic on this show. I believe it's one of the most beautiful languages on this planet and I hope that Arabic-speaking people feel represented.' She is also set to be filming in London throughout next year. Meanwhile, Joshua is gearing up to return to his home in LA, which had to be rebuilt after being destroyed in the wildfires.

2 Recession-Proof Stocks to Buy and Hold
2 Recession-Proof Stocks to Buy and Hold

Yahoo

timean hour ago

  • Yahoo

2 Recession-Proof Stocks to Buy and Hold

Even amid an uncertain economic environment, reliable companies can be found. Zoetis helps people care for pets, which many consider as honorary family members. HCA Healthcare offers services in high demand, regardless of economic conditions. 10 stocks we like better than Zoetis › President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of companies that can perform relatively well even in bad times. These corporations often have robust underlying businesses built to deliver consistent results and superior returns over the long run. Here are two great examples for investors to consider: Zoetis (NYSE: ZTS) and HCA Healthcare (NYSE: HCA). Zoetis, a leading animal health company, has faced some challenges over the past year. The company's recent financial results weren't great, and it is dealing with increased competition for some of its growth drivers, including Apoquel, a medicine to treat allergic itch in dogs. However, as Zoetis points out, there is significant whitespace in this niche. It estimates that 13 million dogs are eligible for the medicine but aren't on any prescription, and another 7 million are undertreated. The company currently treats 12 million dogs with Apoquel and Cytopoint, a similar medicine. Although Zoetis markets products for livestock, poultry, and other animals, the company's work with pets, particularly cats and dogs, is one of the primary reasons it can survive a recession relatively unscathed. People view their pets as family members and are more than willing to pay a significant amount to ensure they are well cared for. The increased humanization of pets should also be a significant long-term growth driver for Zoetis, a trend that is particularly prevalent among younger generations, who are less likely to have children than older ones. It might be pushing it to say that pets are the new kids, but it's not too far from the truth for many pet owners. The rest of Zoetis' business grants it significant diversity. The animal health leader generally grows its revenue at rates faster than the industry average, something it has been able to do for a while, despite competition, through the continuous development of newer medicines. Two of its more recent important approvals, Solensia and Librela that treat osteoarthritis pain in cats and dogs, respectively, are becoming key growth drivers, too. So, despite being slightly in the red over the trailing-12-month period, Zoetis is well-equipped to handle a recession if one is coming, while delivering strong returns in the long run. Lastly, the stock is also an excellent pick for income seekers despite its unimpressive forward yield of 1.2%. Zoetis has increased its payouts by 502% in the past decade. Whether it's for dividends or growth, the healthcare specialist is a great option. HCA Healthcare's business remains in high demand even in recessions. The company is a leading hospital chain in the U.S., and even during economic downturns, people still require critical medical care. True, some procedures performed in the company's facilities are optional. Even for those that aren't, patients may sometimes postpone them when things get tough. So, there will be an impact on the company's results, but it should be fairly minimal. Over the past year, the company has faced another source of headwinds. Various natural disasters, including hurricanes, impacted its financial results in some areas, resulting in lower revenue than anticipated. Still, HCA Healthcare continues to deliver decent updates. In the first quarter, the company's revenue increased by a modest 5.7% year over year to $18.3 billion. Its earnings per share came in at $6.45, up 8.8% compared to the year-ago period. Despite this headwind, HCA Healthcare's long-term prospects are attractive. An aging population that will require more medical care should lead to increased spending on precisely the kinds of services it offers. HCA Healthcare has also deepened its relationships with physicians, patients, and third-party payers over time, partly through the adoption of more services. It would be challenging for any newcomer to seriously challenge HCA Healthcare, considering the ecosystem it has already built, which arguably grants it a network effect. Although there is competition, HCA Healthcare has generally increased its market share over the past decade. The stock should continue delivering superior returns long after the next recession hits, whenever that happens. Before you buy stock in Zoetis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Zoetis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Zoetis. The Motley Fool recommends HCA Healthcare. The Motley Fool has a disclosure policy. 2 Recession-Proof Stocks to Buy and Hold was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store